These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 22544690

  • 1. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.
    Karthick V, Shanthi V, Rajasekaran R, Ramanathan K.
    Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690
    [Abstract] [Full Text] [Related]

  • 2. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
    Woods CJ, Malaisree M, Pattarapongdilok N, Sompornpisut P, Hannongbua S, Mulholland AJ.
    Biochemistry; 2012 May 29; 51(21):4364-75. PubMed ID: 22574858
    [Abstract] [Full Text] [Related]

  • 3. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
    Li L, Li Y, Zhang L, Hou T.
    J Chem Inf Model; 2012 Oct 22; 52(10):2715-29. PubMed ID: 22998323
    [Abstract] [Full Text] [Related]

  • 4. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
    Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D'Souza H, Komadina N, Shaw R, Kelso A, Barr IG.
    Antiviral Res; 2009 Jul 22; 83(1):90-3. PubMed ID: 19501261
    [Abstract] [Full Text] [Related]

  • 5. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
    Park JW, Jo WH.
    J Chem Inf Model; 2009 Dec 22; 49(12):2735-41. PubMed ID: 19957991
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
    Wang B, Dwyer DE, Blyth CC, Soedjono M, Shi H, Kesson A, Ratnamohan M, McPhie K, Cunningham AL, Saksena NK.
    Antiviral Res; 2010 Jul 22; 87(1):16-21. PubMed ID: 20385168
    [Abstract] [Full Text] [Related]

  • 10. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A, Soliman ME.
    Drug Des Devel Ther; 2015 Jul 22; 9():4137-54. PubMed ID: 26257512
    [Abstract] [Full Text] [Related]

  • 11. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Duwe SC, Wedde M, Birkner P, Schweiger B.
    Antiviral Res; 2011 Jan 22; 89(1):115-8. PubMed ID: 21070812
    [Abstract] [Full Text] [Related]

  • 12. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
    Baz M, Abed Y, Simon P, Hamelin ME, Boivin G.
    J Infect Dis; 2010 Mar 22; 201(5):740-5. PubMed ID: 20100088
    [Abstract] [Full Text] [Related]

  • 13. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Abed Y, Nehmé B, Baz M, Boivin G.
    Antiviral Res; 2008 Feb 22; 77(2):163-6. PubMed ID: 17919743
    [Abstract] [Full Text] [Related]

  • 14. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C, Kondo H, Dapat IC, Baranovich T, Suzuki Y, Shobugawa Y, Saito K, Saito R, Suzuki H.
    Antiviral Res; 2013 Sep 22; 99(3):261-9. PubMed ID: 23791870
    [Abstract] [Full Text] [Related]

  • 15. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
    Abed Y, Baz M, Boivin G.
    Antivir Ther; 2006 Sep 22; 11(8):971-6. PubMed ID: 17302366
    [Abstract] [Full Text] [Related]

  • 16. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
    Baek YH, Song MS, Lee EY, Kim YI, Kim EH, Park SJ, Park KJ, Kwon HI, Pascua PN, Lim GJ, Kim S, Yoon SW, Kim MH, Webby RJ, Choi YK.
    J Virol; 2015 Jan 22; 89(1):287-99. PubMed ID: 25320319
    [Abstract] [Full Text] [Related]

  • 17. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
    Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, Lina B, Morfin F, Ferraris O.
    J Clin Virol; 2008 Jan 22; 41(1):25-8. PubMed ID: 18055253
    [Abstract] [Full Text] [Related]

  • 18. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
    Nguyen HT, Trujillo AA, Sheu TG, Levine M, Mishin VP, Shaw M, Ades EW, Klimov AI, Fry AM, Gubareva LV.
    Antiviral Res; 2012 Mar 22; 93(3):381-6. PubMed ID: 22330888
    [Abstract] [Full Text] [Related]

  • 19. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ, Du QS, Huang RB, Zhang DW, Chou KC.
    Biochem Biophys Res Commun; 2009 Aug 28; 386(3):432-6. PubMed ID: 19523442
    [Abstract] [Full Text] [Related]

  • 20. Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.
    Hanpaibool C, Leelawiwat M, Takahashi K, Rungrotmongkol T.
    J Comput Aided Mol Des; 2020 Jan 28; 34(1):27-37. PubMed ID: 31773463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.